List of insiders holdings for Cidara Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Mundipharma AG 10% Owner |
2019-09-13 16:35:41 | 4,781,408 0 |
4,781,408 | Form 13G |
2 | ROCKLAGE SCOTT M 5AM Co-Investors III L.P. 5AM VENTURES III L.P. DIEKMAN JOHN D Schwab Andrew J. Director 10% Owner |
2021-02-16 11:39:44 | 2,006,511 0 |
2,006,511 | Form 13G |
3 | Kjellson Nina S Director |
2015-04-22 14:45:54 | 0 1,356,813 |
1,356,813 | Form 4 |
4 | ELMS STEVE Director |
2015-04-22 19:39:03 | 0 1,054,610 |
1,054,610 | Form 4 |
5 | Aisling Capital II LP AISLING CAPITAL PARTNERS LP AISLING CAPITAL PARTNERS LLC SCHIFF ANDREW N Purcell Dennis J Seachaid Pharmaceuticals Inc. 10% Owner |
2019-02-11 16:06:54 | 1,027,843 0 |
1,027,843 | Form 13G |
6 | Heron Patrick J Director |
2015-04-22 14:49:35 | 0 291,023 |
291,023 | Form 4 |
7 | Stein Jeffrey President & CEO |
2025-04-02 18:28:15 | 275,000 0 |
275,000 | Form 4 |
8 | Levine James E. Chief Financial Officer |
2021-03-19 21:12:52 | 199,803 50,000 |
249,803 | Form 4 |
9 | Daruwala Paul Chief Operating Officer |
2022-09-13 18:40:52 | 221,099 0 |
221,099 | Form 4 |
10 | Judice Kevin Director |
2015-04-14 19:48:33 | 186,553 0 |
186,553 | Form 3 |
11 | KARBE FRANK Chief Financial Officer |
2025-02-26 18:31:07 | 172,500 0 |
172,500 | Form 4 |
12 | Sandison Taylor Chief Medical Officer |
2024-10-02 17:30:20 | 166,836 0 |
166,836 | Form 4 |
13 | Forrest Kevin Chief Scientific Officer |
2017-04-04 16:40:56 | 132,354 0 |
132,354 | Form 4 |
14 | Shah Preetam Chief Financial Officer |
2024-10-02 17:19:12 | 130,087 0 |
130,087 | Form 4 |
15 | Ward Shane COO & CLO |
2025-04-02 18:27:34 | 89,674 0 |
89,674 | Form 4 |
16 | Thye Dirk Chief Medical Officer |
2016-03-18 16:05:44 | 80,000 0 |
80,000 | Form 4 |
17 | Johnson Brady Vice President, Finance |
2022-04-04 17:23:57 | 79,366 0 |
79,366 | Form 4 |
18 | Onaitis Matthew Gnrl Counsel, CFO & Secretary |
2018-04-02 17:18:55 | 72,000 0 |
72,000 | Form 4 |
19 | Abdollahian Neil Chief Business Officer |
2021-04-05 18:24:31 | 57,471 0 |
57,471 | Form 4 |
20 | Bartizal Ken Chief Development Officer |
2017-04-04 16:46:46 | 50,000 0 |
50,000 | Form 4 |
21 | Gollaher David L Director |
2023-06-23 17:15:46 | 42,500 0 |
42,500 | Form 4 |
22 | Franson Timothy R Director |
2023-06-23 17:21:26 | 42,500 0 |
42,500 | Form 4 |
23 | Resnick Joshua Director |
2025-01-07 18:38:27 | 22,200 0 |
22,200 | Form 4 |
24 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director |
2025-01-07 17:42:18 | 0 22,200 |
22,200 | Form 4 |
25 | BURGESS DANIEL D Director |
2024-12-19 18:20:55 | 20,500 0 |
20,500 | Form 4 |
26 | Schroeder Theodore R Director |
2024-12-19 18:19:35 | 20,500 0 |
20,500 | Form 4 |
27 | Wilson Marc Chief Accounting Officer |
2017-09-19 16:44:14 | 20,356 0 |
20,356 | Form 4 |
28 | Mineo Chrysa Director |
2024-12-19 18:18:29 | 19,000 0 |
19,000 | Form 4 |
29 | Tari Leslie CHIEF SCIENTIFIC OFFICER |
2025-03-13 18:33:34 | 16,215 73 |
16,288 | Form 4 |
30 | Canale-Theakston Carin Director |
2024-12-19 18:15:15 | 16,000 0 |
16,000 | Form 4 |
31 | Bassler Bonnie L Director |
2024-12-19 18:17:13 | 16,000 0 |
16,000 | Form 4 |
32 | ROCKLAGE SCOTT M Director |
2018-06-15 21:44:12 | 11,000 0 |
11,000 | Form 4 |
33 | PEREZ ROBERT J Director |
2017-06-26 17:10:08 | 11,000 0 |
11,000 | Form 4 |
34 | Oien Jessica General Counsel & Secretary |
2021-04-05 17:35:45 | 7,764 0 |
7,764 | Form 4 |
35 | Merson James Director |
2024-07-19 16:53:32 | 2,125 0 |
2,125 | Form 4 |
36 | Spencer Ryan Director |
2024-07-19 16:40:06 | 2,125 0 |
2,125 | Form 4 |
37 | Tadvalkar Laura Director |
2024-07-19 16:38:59 | 2,125 0 |
2,125 | Form 4 |
38 | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
2022-02-11 16:48:00 | 0 0 |
0 | Form 13G |